Correlation Between Visa and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Visa and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Moleculin Biotech, you can compare the effects of market volatilities on Visa and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Moleculin Biotech.
Diversification Opportunities for Visa and Moleculin Biotech
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Visa and Moleculin is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Visa i.e., Visa and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Visa and Moleculin Biotech
Taking into account the 90-day investment horizon Visa is expected to generate 1.66 times less return on investment than Moleculin Biotech. But when comparing it to its historical volatility, Visa Class A is 5.98 times less risky than Moleculin Biotech. It trades about 0.34 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 245.00 in Moleculin Biotech on September 4, 2024 and sell it today you would earn a total of 24.00 from holding Moleculin Biotech or generate 9.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. Moleculin Biotech
Performance |
| Timeline |
| Visa Class A |
| Moleculin Biotech |
Visa and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Moleculin Biotech
The main advantage of trading using opposite Visa and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |